RT期刊文章SR电子T1创新招聘策略的多样性增加参与狐狸洞察力纵向队列(S16.009)摩根富林明神经病学神经学乔FD Lippincott Williams &威尔金斯SP S16.009 VO 92 15补充A1罗珊娜Dobkin A1 Ninad Amondikar A1切尔西Caspell-Garcia A首页1吉娜巴恩斯A1劳伦借A1拉娜夏英A1安德里亚·卡茨A1凯瑟琳Kopil A1康尼马拉A1阿曼达Melnick A1 Traci Schwieger A1 Bernadette Siddiqi A1班图语Smolensky A1大卫Standaert A1卡罗琳·坦纳年2019 UL //www.ez-admanager.com/content/92/15_Supplement/S16.009.abstract AB目的:为了真正推动帕金森病(PD)研究和临床护理,创新招聘策略需要准确地捕捉病人报告结果来自不同领域的PD社区。这个项目的目标是检查特定的数字营销活动是否与有针对性的入学人数增加有关狐狸的洞察力研究(早期和晚期疾病,未被充分代表的地理区域),相对于基线期和没有特别的促销活动,并进一步描述了PD的临床和人口特征样本招募通过不同的方法。背景:迈克尔·j·福克斯帕金森氏症研究基金会(MJFF)最近推出了福克斯的洞察力-一个虚拟,纵向观察研究,收集病人报告结果数据(例如,身心健康,生活质量,医疗利用率)从125000年PD患者和健康对照组5年。25000名参与者。设计/方法:一个基线(干预前),确定为6周,没有特殊促销(组1),是比较独特的Facebook和谷歌广告针对特定PD组(早/晚阶段PD,那些生活在未被充分代表的地理区域(组2 - 4)],以及更一般的网上推广的研究(5).Results:每个数字运动成功地招募更多的总主题与基线相比,虽然只有一个(针对弱势地区基于邮政编码)是成功的在招聘目标人口的比例更高。五组不同显著在关键变量。例如,与基线相比,早期和晚期阶段PD集中活动招募更多元化的人口总体而言,对人口统计数据(之前更多的低收入,少受过高等教育,临床参与,更高比例的拉丁美洲裔人士)和病史(更多的医学并存病)。结论:有针对性的数字招聘方法有潜在的多元化的人口和临床组成狐狸洞察力队列和那些参加PD研究一份。披露:Dobkin博士没有披露。Amondikar博士没有披露。Caspell-Garcia博士没有披露。Barnes博士没有披露。借博士没有披露。 Dr. Chahine has nothing to disclose. Dr. Katz has nothing to disclose. Dr. Kopil has nothing to disclose. Dr. Marras has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Grey Matter Technologies LLC. Dr. Melnick has nothing to disclose. Dr. Schwieger has nothing to disclose. Dr. Siddiqi has nothing to disclose. Dr. Smolensky has nothing to disclose. Dr. Standaert has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Serina Therapeutics, Abbvie Inc., the Michael J. Fox Foundation for Parkinson Research, The International Parkinson Disease and Movement Disorder Society, The Parkinson Foundation, the National Institutes of Health, Oregon Health Sciences University, Voyager Therapeutics, Blue Rock Therapeutics, Clintrex LLC, Revivo Therapeutics, Sanofi-Adventis Research and Development, and US Department of Justice. Dr. Standaert has received license feed payments, royalties, or contractual rights from McGraw Hill, Inc. Dr. Standaert has received research support from Abbvie, Inc., Avid Radiopharmaceuticals, the American Parkinson Disease Association, the Michael J. Fox Foundation for Parkinson Research, Alabama Department of Commerce, the Bachmann-Strauss Dystonia; Parkinson Foundation, and NIH grants. Dr. Tanner has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Adamas, Neurocrine, Photopharmics, Biotie Therapeutics, Alexza, 23andMe, INTEC Pharma, Voyager Therapeutics, Grey Matter Technologies LLC. Dr. Tanner has received research support from BioElectron, Roche.